In vitro, leptin has been shown to elicit mitogenic, angiogenic and anti-apoptotic effects when administered to oesophageal adenocarcinoma cell lines, enhancing cellular proliferation [54–57]. The gene discussed is LEP; the disease is esophageal adenocarcinoma.